Letter by Rozenbaum et al Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy"
- PMID: 33044864
- DOI: 10.1161/CIRCULATIONAHA.120.046955
Letter by Rozenbaum et al Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy"
Comment in
-
Response by Kazi et al to Letter Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy".Circulation. 2020 Oct 13;142(15):e212-e213. doi: 10.1161/CIRCULATIONAHA.120.049842. Epub 2020 Oct 12. Circulation. 2020. PMID: 33044859 Free PMC article. No abstract available.
Comment on
-
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy.Circulation. 2020 Apr 14;141(15):1214-1224. doi: 10.1161/CIRCULATIONAHA.119.045093. Epub 2020 Feb 12. Circulation. 2020. PMID: 32078382 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials